Skip to main content

Gout

Rheumatology Consultant
What do you observe as the main reason for nonadherence to urate-lowering therapy among your patients? Let us know by taking our quick poll!
Rheumatology Consultant
Dr Solomon discusses what rheumatologists should know about interleukin-1β inhibitors, his research on the relationship between the inhibitors and gout, and more.
Rheumatology Consultant
Acute gout in frequently responsible ED visits, which are a major source of opioid prescriptions. In a recent study, researchers sought to assess the burden of opioid use among gout patients discharged from the ED.
Rheumatology Consultant
The authors of a new study measured opioid use and factors associated with it among more than 400 individuals with gout who were discharged from an emergency department.
Rheumatology Consultant
Julianna Desmarais, MD, answers our questions on her new study about the efficacy and safety of anakinra in the management of acute gout and pseudogout.
Back to Top